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Aim: To provide insight in the primary health care (PHC) case management of febrile
children under-five in Dar es Salaam, and to identify areas for improving quality of care.
Methods: We used data from the routine care arm of the ePOCT trial, including children
aged 2–59 months who presented with an acute febrile illness to two health centers
in Dar es Salaam (2014–2016). The presenting complaint, anthropometrics, vital signs,
test results, final diagnosis, and treatment were prospectively collected in all children.
We used descriptive statistics to analyze the frequencies of diagnoses, adherence to
diagnostics, and prescribed treatments.
Results: We included 547 children (47%male, median age 14 months). Most diagnoses
were viral: upper respiratory tract infection (60%) and/or gastro-enteritis (18%). Vital signs
and anthropometric measurements taken by research staff and urinary testing failed to
influence treatment decisions. In total, 518/547 (95%) children received antibiotics, while
119/547 (22%) had an indication for antibiotics based on local guidelines. Antibiotic
dosing was frequently out of range. Non-recommended treatments were common (29%),
most often cough syrup and vitamins.
Conclusion: Our study points to challenges in using diagnostic test results, concerns
regarding quality of antibiotic prescriptions, and frequent use of non-evidence-based
complementary medicines in PHC in Tanzania. Larger studies on diagnostic and
treatments processes in PHC in Tanzania are needed to inform effective solutions to
support PHC workers in case management of children.
Keywords: infectious diseases, low-resource setting, primary care, quality of care, decision-support, pediatrics,
fever
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INTRODUCTION
Child health has improved over the last 20 years in the United
Republic of Tanzania. In 2013, the country attained the 4th
Millennium Development Goal target—to reduce the under-
5 mortality rate by two-thirds from 1990 levels (1). Part of
this progress is related to the strengthening of primary health
care (PHC) and the implementation of the World Health
Organization (WHO) Integrated Management of Childhood
Illnesses (IMCI) strategy (2). However, mortality rates in
children under-five remain high compared to other settings,
and infectious diseases are still a main driver of childhood
mortality in low-resource settings (3). Timely and accurate
diagnosis and treatment of febrile children in PHC is essential
to continue improving health outcomes in this vulnerable
patient group. Primary care case management of children with
acute febrile illnesses follows the IMCI chart booklet, a set of
simple, evidence-based clinical treatment guidelines for settings
in which sophisticated diagnostic equipment is not available (4).
In addition to IMCI, countries usually have national treatment
guidelines in use (5).
Besides the availability of evidence-based guidelines, effective
implementation of these guidelines and adherence to their
recommendations in clinical practice are crucial, but often
poor (6–19). Over the past years, antibiotic over-prescription
for children at PHC facilities has become a growing concern
(20). This is especially true for febrile children, which represent
the vast majority of children presenting to primary care (21).
Through a better understanding of diagnostic and care processes,
including challenges faced by clinicians, more effective strategies
to improve quality of care could be developed. To date, more
granular data on the quality of facility-based IMCI care in low-
resource settings are still needed (7, 12–14, 22, 23). Most studies
on adherence to IMCI have focused on clinical assessments and
provider factors (12–14). Fewer, smaller studies focused on the
diagnostic and treatment pathways (7, 22).
We provide data from the routine care cohort of the ePOCT
study, a randomized controlled trial in primary care in Dar es
Salaam, Tanzania. The ePOCT study investigated the impact
of a novel electronic decision algorithm (ePOCT) on the
management of febrile children, compared to using an electronic
version of IMCI (24). It also included a prospective routine care
cohort to monitor primary care treatment practices in the study
area. The present study aims at describing the case management
of febrile children under-five enrolled in this cohort study, and to
identify areas for improving quality of care.
MATERIALS AND METHODS
Study Design
This is a prospective cohort study of febrile children in
primary care in Dar es Salaam, Tanzania, collected as a routine
Abbreviations: CRP, c-reactive protein; ePOCT, study investigating the impact
of a novel electronic decision algorithm; IMCI, Integrated Management of
Childhood Illnesses; mRDT, malaria rapid diagnostic test; MUAC, mid-upper-
arm-circumference; ORS, rehydration solution; PHC, primary health care; RR,
respiratory rate; T, temperature; URTI, respiratory tract infection; UTI, urinary
tract infection; WHO, World Health Organization.
care cohort in parallel to the ePOCT randomized controlled
trial. The main outcome measures were the frequencies of
and coherence between presenting complaints, diagnostic tests,
provider diagnoses and treatment. In addition, we studied the
adherence to treatment recommendations of the IMCI chart
booklet and national guidelines.
Setting
Data were collected in a convenience sample of two neighboring
public health centers of the study facilities in the Kindondoni
District, Dar es Salaam, Tanzania (Facility A and B). Routine
clinicians managing febrile children in the participating health
centers were asked to take part in the study. In facility A care
was provided by two clinicians (clinician 1 and 2) and in facility
B by one clinician (clinician 3). All clinicians were certified
clinical officers. Clinical officers undergo a 3 year training in
basic and applied medicine, and are responsible for the health
care of large dispersed rural populations (25). They treat patients
independently, without supervision from medical doctors. All
clinicians were trained in IMCI but also used the Tanzanian
Standard Treatment Guidelines (4, 26). IMCI includes systematic
testing for malaria using a malaria rapid diagnostic test (mRDT).
As part of the study, vital sign measurements and mRDT results
were provided to the clinician. All essential medicines were made
available at the facilities during the study (26).
Population
This study included children aged 2 to 59 months who presented
consecutively with an acute febrile illness to the included health
centers. The same inclusion and exclusion criteria as the ePOCT
trial were used (briefly: history of fever for <7 days and axillary
temperature [T] ≥ 37.5◦C, no acute poisoning, or trauma)
(24). Written informed consent was obtained from all parents
or guardians.
Data Collection
Data collection took place from December 2014 to February
2016. A trained research assistant saw the patients first,
collected data in a predefined case report form on presenting
complaints of the child (as reported by the caregiver) and
measured basic anthropometrics and vital signs: weight, mid-
upper-arm-circumference (MUAC), axillary temperature (T),
and respiratory rate (RR). In addition, the research assistant
inquired systematically about the presence of cough or difficulty
breathing. The research assistant also performed an mRDT in
all included children. Other diagnostic tests were ordered at the
discretion of the treating clinicians. Test results were recorded
on a study form by the research assistant. Clinicians were asked
to record their diagnoses and prescribed treatments with dosing.
Before discharge of the patient, the research assistant checked
whether these diagnoses and treatments corresponded to those
noted by the clinician in the patient’s chart, and clarified all
discrepancies with the clinician. Research staff did not interfere
with the provider diagnoses, nor with treatments. Health worker
consultations were not observed by study staff. It was ensured
that all essential medicines were available during the conduct of
the study (26). Additional medicines prescribed by the providers
were generally purchased by parents in private pharmacies.
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Telephone follow-up was performed in all children at day 3,
day 7 and day 30 after the visit to the health center. In case
children had not recovered at day 7, an additional follow-up was
performed at day 14.
Definitions
For the purpose of this analysis, “recommended treatments
per clinical diagnosis” were based on the 2008 IMCI and the
Standard Treatment Guidelines of Tanzania from 2013 (4, 26).
These guidelines were in use during the data collection of
the study. If prescribed treatments were not mentioned in
these guidelines, other international guidelines were used to
define recommended dosages (27–29). Adherence to mRDT
test results was defined as not prescribing antimalarial drugs
to a patient when the mRDT result was negative, and
treating patients with a positive mRDT result with antimalarial
drugs. The spectrum of antibiotics was defined in line with
other comparative studies on antibiotic prescription (30–32).
The following antibiotics were classified as broad-spectrum:
penicillins (including beta-lactamase inhibitors), second- and
third-generation cephalosporins, macrolides, aminoglycosides,
sulfamethoxazole-trimethoprim, tetracyclines, quinolones and
chloramphenicol. Other penicillins (including amoxicillin), first-
generation cephalosporins and metronidazole were classified as
narrow-spectrum. Since clinicians frequently used diagnoses not
contained in the IMCI classifications, we did not attempt re-
classification of diagnoses per the IMCI diagnostic classifications.
Certain diagnoses were grouped per Supplementary File 1 for
data analysis. Positive urine dipstick was defined as the presence
of either nitrite or leucocytes.
Statistical Analysis
We used the following descriptive statistics: frequencies of
presenting complaints, clinical diagnoses, diagnostic tests,
treatments and dosages were calculated.We tested for differences
in provider diagnoses and treatments between clinicians using
chi-square tests.We also populated 95% confidence intervals (CI)
for proportions to allow comparison between providers. Analyses
were performed in Stata version 15.1 and SPSS version 25.
Patient and Public Involvement
There was no patient or public involvement in the design or
conduct of this study, nor in the writing of this manuscript.
Ethics
The original ePOCT study protocol and related documents
were approved by the institutional review boards of the
Ifakara Health Institute and the National Institute for Medical
Research in Tanzania (NIMRrHQ,R.8a,/trI’VoIl. 789), by the
Ethikkommission Beider Basel in Switzerland (EKNZ UBE
15/03), and the Boston Children’s Hospital ethical review
board. Written informed consent was obtained from all parents
or guardians.
TABLE 1 | Baseline characteristics.
Demographics n/N (%) or median (IQR)
Male sex 259/547 (47%)
Age in months 14 (9–21)
Age group
- 2–11 months 225/547 (41%)
- 12–23 months 206/547 (38%)
- 24 months and older 116/547 (21%)
Primary care giver
- Mother 506/514 (98%)
- Father or grandparents 8/514 (2%)
Number of children <18y in household 2 (1–2)
Educational level mother
- None 30/514 (6%)
- Primary school 348/514 (68%)
- Post primary school 130/514 (25%)
- Post secondary school 6/514 (1%)
Seasona
- Rainy 44/547 (8%)
- Post rainy 106/547 (19%)
- Dry 397/547 (73%)
Health center
- Facility A, clinician 1 149/547 (27%)
- Facility A, clinician 2 234/547 (43%)




Cured at day 3 473/523 (90%)
Cured at day 7 534/544 (98%)
Cured at day 14 (from those not cured at d7) 10/10 (100%)
Died (at day 20) 1/547 (0%)
aRainy season in the study area was March to May, post rainy season June to July, dry
season August to February.
bNot all patients could be reached by telephone during follow-up, resulting in 24 patients
with missing follow-up at day 3 and 3 with missing follow-up at day 7.
RESULTS
Population
In total 547 children were included (Table 1 and Figure 1), each
of the three participating clinicians assessed approximately one
third of the population. The population resembled the primary
care population in Dar es Salaam of being relatively young
(median age 14 month) and presenting mostly with mild disease
(7/547 [1%] of children required hospital admission until day 7
follow-up). All children were cured after 2 weeks, but one died at
day 20 of follow-up.
Presenting Complaints and Provider
Diagnoses
The most prevalent caregiver-reported presenting complaints
other than fever (an inclusion criterion), were cough, or
symptoms suggestive of an upper respiratory infection (runny
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FIGURE 1 | Flowchart of inclusion.
nose, sore throat), see Supplementary File 2. Almost half of
the children (249/547, 45%) had two or more presenting
complaints besides fever. The most prevalent provider diagnoses
were “upper respiratory tract infection (URTI),” “gastroenteritis,”
“malaria” and “urinary tract infection (UTI),” as presented in
Supplementary File 2. A quarter of the population received two
or three diagnoses. Most frequent co-occurring diagnoses were
“URTI” and “gastroenteritis” (n = 38), “URTI” and “malaria”
(n = 31), “URTI” and “UTI” (n = 17) and “malaria” and
“UTI” (n = 16), but also many other combinations were present
(Table 2). There was significant variability in the five most
prevalent diagnoses across clinicians, though differences were
not clinically significant besides for malaria (<14% overlap in
the 95% CI for all proportions, see below for malaria diagnosis,
Supplementary File 3).
Use of and Adherence to Diagnostic Tests
Other than the mRDT (performed by research personnel in all
children), diagnostic tests were ordered for 54/547 (10%) of
children (Supplementary File 4). Urine dipstick was ordered in
46 cases, but obtained in 31. HIV tests were performed in 2/547
(<1%) of children. An opt-out strategy for HIV testing was in
place at the time of the study (i.e., a voluntary HIV test should
have been offered to all children presenting for care). Table 3
shows the diagnostic pathways for malaria and UTI. 46/547
(8%) of children were mRDT positive. Average adherence to
mRDT results was low (30/46 [65%] of mRDT positive cases were
prescribed an antimalarial,Table 3) but this wasmainly driven by
one clinician, (clinician 1 and 2 together prescribed antimalarials
to 28/31 [90%] and 12/13 [92%] of malaria and malaria diagnosis
only cases, respectively. Clinician 1 and 2 together prescribed
antimalarials to 4/34 [12%] of mRDT negative cases, see Table 3).
In total 83 children were diagnosed with “UTI,” of whom 14/83
(17%) underwent urine dipstick testing and 79/83 (95%) were
treated with antibiotics. Among the 31 children tested by urine
dipstick, the diagnosis of “UTI” was not associated with a positive
urine dipstick (either nitrite or leucocytes present) (Fisher’s exact
test p = 0.20). A urine dipstick was ordered for a variety of
complaints (Table 3), 8/54 (15%) with a complaint of “fever
only” had a urine dipstick ordered (2/31 [7%] of children <24
months). Three of the 4 children diagnosed with “anemia” had a
hemoglobin test done, with results <9 g/dL.
Coherence of Clinical Measurements With
Diagnoses
Besides axillary temperature (which was an inclusion criterion
for the study), weight, MUAC, and RR were measured in all
children by trained study staff and made available to the treating
clinician. Study staff also specifically inquired about the presence
of cough or difficulty breathing. Based on the combination of
fever, cough, and elevated respiratory rate (as per IMCI cutoffs),
146/363 (40%) of children with respiratory complaints met the
IMCI pneumonia classification; 16/146 (11%) of those received
a diagnosis “pneumonia” by the clinician; 120/146 (82%) were
diagnosed as “URTI” (Table 4). Fifteen patients (15/547, 3%) had
a weight for age <-3 z-score per the WHO growth reference, 1
child also had a MUAC <11.5 cm. One child received a diagnosis
of “malnutrition” but this child neither had low weight for age
nor low MUAC.
Antibiotic Treatment
Ninety-five percent of the children received an antibiotic
treatment (518/547, Table 5A). Amoxicillin was prescribed most
frequently (282/518, 54%), followed by cephalexin (134/518,
26%) (Table 5A). Of all children receiving antibiotics, 90/518
(17%) received broad-spectrum antibiotics. 182/547 children
(33%) received broad-spectrum ormultiple antibiotics. Injectable
antibiotics were prescribed in 103/547 (19%) of patients, of
which only two had a severe diagnosis indicating the need
for intramuscular pre-referral antibiotic treatment. Based on
the diagnoses of the clinician, 119/547 (22%) of children
had an indication for antibiotic treatment based on IMCI or
Tanzanian national guidelines (Supplementary File 5). At least
one indicated antibiotic per IMCI or national guidelines was
prescribed in 17/119 (14%) of children with an indication for
antibiotic treatment (Supplementary File 5). “Appropriateness”
did not vary significantly by clinician (chi square p= 0.40).
A first-line recommended antibiotic treatment was prescribed
in 11/31 (36%) of children with a “pneumonia” diagnosis. 82/146
(56%) of children with an IMCI pneumonia classification based
on the research staff measurements were prescribed a first-line
antibiotic treatment (Table 4). Among those with a “UTI”
diagnosis, most children (42/83, 51%) received amoxicillin,
whereas 3/83 (4%) received the first-line recommended
treatment amoxicillin/clavulanic acid. Children who were only
diagnosed with “gastroenteritis” (n = 51) were prescribed
antibiotics in 92% of cases, although these infections are mostly
viral. Details of prescribed antibiotics for the most frequent
infections can be found in Table 5A.
For prescribed antibiotics, dosing errors were frequent
(Table 6). The prescribed dose for amoxicillin was too low
in about one-third of prescriptions based on guidelines in
use. Out-of-range prescribing was not significantly different
among clinicians (chi square p = 0.78 for dosing within WHO
2008 range, data not shown). All six recorded azithromycin
prescriptions were too high (range 17–71 mg/kg/day). For
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TABLE 2 | Co-occurring diagnoses.
URTI Gastroenteritis Malaria Urinary tract infection Skin infection Vitamin deficiency
Gastroenteritis 38
Malaria 31 4
Urinary tract infection 17 6 16
Pneumonia 1 0 1 5 0 0
Skin infection 4 2 3 2
Fever without source 0 0 2 1 1 0
Oral thrush 4 2 0 1 0 0
Vitamin deficiency 3 1 1 4 0
URTI, upper respiratory tract infection.
TABLE 3 | Compliance to recommended diagnostic tests.
Malaria Urinary tract infection (UTI)
Diagnosis Diagnosis
Malaria 85/547 (16%) UTI 83/547 (15%)
Malaria only 30/547 (5%) UTI only 33/547 (6%)
Diagnostic tests Diagnostic tests
All patients routinely tested by mRDT per study procedures independent of main complaint. Main complaints in patients with ordered urine dipstick
Cough 23/46 (50%)
Upper respiratory infection 10/46 (22%)
Diarrhea 12/46 (26%)
Fever only 8/46 (17%)
Vomiting 7/46 (15%)
Abdominal pain 6/46 (13%)
Dysuria 2/46 (4%)
mRDT in patients with malaria diagnosis (N = 85) Urine dipstick in patients with UTI diagnosis (N = 83)
mRDT positive 43/85 (51%) Urine dipstick ordered 17/83 (20%)
Urine obtained 14/83 (17%)
Urine dipstick positive 5/83 (6%)
mRDT in patients with no malaria diagnosis (N = 459) Urine dipstick in patients without UTI diagnosis (N = 464)
mRDT positive 3/459 (1%) Urine dipstick ordered 29/464 (6%)
Urine obtained 17/464 (4%)
Urine dipstick positive 2/464 (1%)
Treatment Treatment
Recommended: Artemeter-Lumefantrine (Alu) Recommended: antibiotics
Alu in malaria diagnosesa 29/85 (34%) Antibiotics in UTI diagnoses 79/83 (95%)
Alu in malaria only diagnosesa 12/30 (40%) Antibiotics in UTI only diagnoses 33/33 (100%)
Alu in mRDT positivesa 30/46 (65%) Antibiotics in dipstick positives 7/7 (100%)
aThere was significant variation between the three diagnosis in regards to adherence to mRDT results: Clinician 1 and 2 together prescribed Alu to 28/31 (90%) and 12/13 (92%) of
malaria and malaria diagnosis only cases, respectively. Clinician 1 and 2 together prescribed Alu to 4/34 (12%) of mRDT negative cases.
mRDT, malaria rapid diagnostic test; UTI, urinary tract infection.
cephalexin all prescriptions except one were within the range of
25–100 mg/kg/day of the WHO Model Prescribing Information
(27). Co-Trim was in 93% of cases prescribed within the WHO
2008 range; 47% of the erythromycin dosages were too low.
Other Treatments
Besides antibiotics, most frequently prescribed medications
were paracetamol, cough syrup, oral rehydration solution
(ORS), vitamins, and zinc (Table 5B). Recommended treatments
according to guidelines at the time of the study are displayed
in Supplementary File 6. Prescriptions of those prevalent
medications showed some variation between the three clinicians,
but not clinically significant (Supplementary File 3). Zinc was
prescribed in 45/100 (45%), and ORS in 74/100 (74%) of
“gastroenteritis” diagnoses. Cough syrup, which is not indicated
per IMCI but can be considered in children with cough per
the Tanzanian National Treatment Guidelines, was given to
82/336 (24%) of children with cough. Salbutamol was given
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TABLE 4 | Provider diagnoses and antibiotics prescribed for patient meeting IMCI
criteria for pneumonia.
Diagnoses Treatment N (%)




IM penicillin 21 (14%)




IM penicillin 5 (31%)




IM penicillin 10 (8%)




IM penicillin 14 (67%)




IM penicillin 1 (7%)




IM penicillin 2 (15%)
First-line antibiotics indicated per IMCI or the national treatment guidelines are bolded.
aCo-Trim, combination of sulfamethoxazole and trimethoprim.
IMCI, integrated management of childhood illness; URTI, upper respiratory tract infection;
UTI, urinary tract infection; IM, intramuscular.
to 9/547 (1%) of patients; 7 of whom received it both per
os and per inhalator. Treatments not recommended in any
guideline included vitamins in 60/547 (11%), domperidone in
13/547 (2%), antihistamines in 7/547 (1%), and bella donna in
2/547 (1%) of patients. When including cough syrup as a non-
recommended treatment, 161/547 (29%) of children received a
non-recommended treatment.
DISCUSSION
Summary of Main Findings
In this descriptive analysis of primary diagnostic and treatment
practices for febrile children in Dar es Salaam, Tanzania, we
found a very high prevalence of antibiotic prescription. Several
issues around antibiotic prescription were identified, including
a mismatch between diagnoses and antibiotic treatment,
and inaccurate dosing. Misdiagnoses and incorrect treatment
prescriptions were common despite provision of respiratory
rates, weight and MUAC to clinicians. Adherence to mRDT
test results was highly variable. Urine dipstick testing did
not appear to change the diagnostic or treatment process
in this cohort. Prescription of complementary, non-indicated
treatments was frequent.
Strengths and Limitations
Our study has obvious limitations. The cohort was small
and included only three clinicians in two health centers. The
generalizability of the findings is hence very limited. However, we
did not note relevant provider variability across most domains
observed, besides in the treatment of malaria. Dar es Salaam
presents a very specific, urban care setting in Tanzania and our
findings cannot be generalized to other parts of the country. Our
study did not collect data on the consultation process, but rather
only on the “inputs” and “outputs” of the consultation. We were
hence limited in our ability to explain our findings. At the same
time, the lack of observation of the consultation process is also
a strength of our study: previous studies in Tanzania often used
observations of consultations (13, 14, 22), raising concern for a
Hawthorne effect. Even though a Hawthorne effect cannot be
excluded in our study, we believe it is limited in the absence of
direct observation. Our study also removed barriers that have
been previously reported to challenge quality of primary care,
such as the availability of diagnostics and medicines, and the
lack of time to perform anthropometric and RR measurements
(33–35). This allowed us to explore the contribution of such
factors to the diagnostic and treatment process. We also provide
more granular data on medicine prescriptions in primary care
in Tanzania.
Interpretation and Comparison to the
Literature
Overall, our findings point to several challenges faced by
clinicians in managing febrile children, which warrant
further investigation.
The distribution of the infectious diagnoses (with 68% of
diagnoses being likely viral, like URTI and gastroenteritis) reflects
recent epidemiological evidence of the study area (36, 37). The
high number of viral diagnoses is a change from a recent study
in the same area, where under-classification of viral illnesses
was found (22). UTI appeared to be over-diagnosed in our
cohort [15% of patients vs. an estimated prevalence of around
3–5% reported by similar studies (36, 37)]. Other bacterial
infections such as pneumonia and ear infections seemed to be
under-diagnosed, although most often covered by antibiotics for
other diagnoses.
Interestingly, clinicians hardly used IMCI classifications for
their diagnoses, but rather used diagnoses such as “upper
respiratory tract infection” and “gastroenteritis” found in
national guidelines and standard pediatric textbooks. Especially
as Tanzania is moving toward a national electronic medical
record system, it will be important to understand how diagnoses
are used by primary care clinicians.
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TABLE 5 | Treatments prescribed.











N = 547 N = 327 N = 100 N = 83 N = 31
Any antibiotic 518 (95%) 310 (95%) 96 (96%) 79 (95%) 31 (100%)
Amoxicillin 282 (56%) 196 (60%) 25 (25%) 42 (51%) 11 (35%)
Penicillin 75 (14%) 22 (7%) 3 (3%) 13 (16%) 14 (45%)
Amoxicillin/clavulanic acid 6 (1%) 1 (0%) 0 (0%) 3 (4%) 2 (6%)
Amoxicillin/cloxacillin 30 (6%) 16 (5%) 0 (0%) 6 (8%) 2 (6%)
Cephalexin 134 (25%) 86 (26%) 11 (11%) 22 (26%) 18 (58%)
Ceftriaxone 1 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (3%)
Azithromycin 6 (1%) 3 (1%) 2 (2%) 3 (4%) 0 (0%)
Erythromycin 16 (3%) 3 (1%) 12 (12%) 1 (1%) 0 (0%)
Ciprofloxacin 6 (1%) 0 (0%) 4 (4%) 2 (2%) 0 (0%)
Co-trim 55 (10%) 20 (6%) 51 (51%) 5 (6%) 0 (0%)
Chloramphenicol 1 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (3%)
Gentamicin 2 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (3%)
Metronidazole 4 (1%) 1 (0%) 3 (3%) 0 (0%) 0 (0%)
(B) Other treatments prescribed in all children
Other treatments All children n (%)
N = 547






Skin treatment 16 (3%)
Domperidone 13 (2%)
Salbutamol per os 8 (1%)
Salbutamol inhaler 8 (1%)
Antihistamine 7 (1%)
Eye treatment 3 (1%)
Safe remedies 2 (0%)
Bella donna 2 (0%)
Antibiotic treatment with more than 10% of patients are shaded in gray. Antibiotics indicated per IMCI or the national treatment guidelines are bolded. anon-severe pneumonia.
IMCI, integrated management of childhood illness; URTI, upper respiratory tract infection; UTI, urinary tract infection; ORS, oral rehydration solution.
Two diagnoses, malaria, and UTI, should have been based
on diagnostic testing. For malaria, many studies have raised
concerns about the lack of testing and adherence to test results
(38–41). We also found concerns regarding adherence to mRDT
test results, but the data was driven by a single provider. Urine
dipstick results seemed not to influence treatment decisions in
our study. Urine dipstick is not included within IMCI, but is in
the Tanzanian Standard Treatment Guidelines.
Previous studies pointed to the lack of diagnostic tests as a
main challenge in fever management. Our findings underline
the need for clear guidance and training in the use and
interpretation of diagnostic tests. In addition, a variety of
“know-do” gaps have been described to explain non-adherence
to IMCI guidelines and diagnostic tests, these include a
preference on relying on personal experience, provider priorities,
goodness of fit in routine practices as well as intrinsic and
extrinsic motivation (12, 14, 42). In this context, it is also
interesting that systematically provided RR and anthropometric
measurements did not appear to be taken into consideration
by clinicians. Even though this systematic measurement was
a minor intervention in routine care, it did not seem to
change clinical practice. Previous studies have stipulated that
a lack of RR and anthropometric measurements are the
main barrier to correct classification of IMCI pneumonia and
malnutrition cases, which was clearly not the case in our
study (33–35).
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TABLE 6 | Dosage of antibiotics.
Recommended daily dose Amoxicillin Azithromycin Cephalexin Ciprofloxacin Co-Trima Erythromycin
N = 272 N = 6 N = 133 N = 6 N = 54 N = 15
Dose mg/kg, median (IQR) 44 (38–54) 26 (17–45) 41 (36–47) 31 (23–37) 9 (8–10) 43 (38–54)
WHO 2014 guidelineb
Dose within range 86/272 (32%) 0/6 (0%)
Dose too high 0/272 (0%) 1/6 (17%)
Dose too low 186/272 (68%) 5/5 (83%)
WHO 2008c
Dose within range 191/272 (70%) 0/6 (0%) 50/54 (93%)
Dose too high 4/272 (1%) 1/6 (17%) 0/54 (0%)
Dose too low 77/272 (28%) 5/5 (83%) 4/54 (7%)
Tanzania guidelined
Dose within range 126/272 (46%)
Dose too high 48/272 (18%)
Dose too low 98 (36%)
International guidelinee
Dose within range 174/272 (64%) 0/6 (0%) 132/133 (99%) 5/5 (83%) 17/54 (31%) 7/15 (47%)
Dose too high 0/272 (0%) 6/6 (100%) 0/133 (0%) 1/6 (17%) 32/54 (59%) 1/15 (6%)
Dose too low 98/272 (36%) 0/6 (0%) 1/133 (1%) 0/6 (0%) 5/54 (9%) 7/15 (47%)
atrimetoprim/sulfometoxazole in pediatric tablet 20/100mg, only the trimethoprim dose is mentioned in the table.
bbased on WHO 2014 chart booklet (amoxicillin: 4–10 kg = 500 mg/d; 10–14 kg = 1,000 mg/d; 14–19 kg = 1,500 mg/d. Ciprofloxacin <6months 250 mg/d, 6–59 months 500 mg/d,
or 30 mg/kg/d).
cbased on WHO 2008 chart booklet (amoxicillin: 4–10 kg = 375 mg/d, 10–19 kg = 750 mg/d; Co-Trim: 4–10 kg = 80 mg/d, 10–19 kg = 120 mg/d).
dbased on Tanzanian guideline: for pneumonia, recommended dose is 25 mg/kg every 12 h; 20% dosage variation (40–60 mg/kg/d) was assumed.
ePneumonia amoxicillin: 40–120 mg/kg/d based on WHO CAP (community-acquired pneumonia) evidence update 2016 (28). Rest based on WHO Model Prescribing Information
(27): azithromycin 10 mg/kg/d with 10% dose variation; Cephalexin: 25–100 mg/kg/d; Ciprofloxacin: 20–40 mg/kg/d; Co-Trim 8 mg/kg/d with 10% dose variation; Erythromycin
40–60 mg/kg/d.
WHO, World Health Organization; IQR, interquartile range.
Our findings confirm the concern about high-volume
antibiotic prescription in primary care in Tanzania (20, 37, 43–
45). The almost systematic prescription of antibiotics for viral
infections (e.g., primarily gastroenteritis and URTI) questions
the motivations behind such non-indicated use. Previous studies
have reported many underlying factors to explain inappropriate
antibiotic prescription. These include pressure from families,
discomfort with the possibility that the child could worsen
before returning to care, the perception that bacterial illnesses
are much more common, understaffing, inability to differentiate
causes of illness based on history and physical examination
alone, discomfort with diagnostic uncertainty, and insufficient
knowledge in managing non-malarial fever in children (12,
23, 40, 46). These findings from other studies may also be
a reason for the high volume of medicine prescription in
general. Additional diagnostic testing can improve certainty
about bacterial or viral etiology of febrile illness and could
thereby improve antibiotic prescription. Diagnostic test results
should be readily available at the point of care, where treatment
decisions are made (47). Bacterial culture or parasite microscopy
are unlikely to impact antibiotic prescription in the primary
care setting given the complexity to perform, long duration
to obtain results, and overall inaccessibility. Rapid viral or
antigen tests are usually not available in Sub-Saharan primary
care. Other point-of-care tests like c-reactive protein (CRP)
have shown to improve antibiotic prescription in the primary
care setting in Vietnam (48). In high-income settings, the
impact on antibiotic prescription has been variable (49–51).
The combination of point-of-care tests and clinical information
seems to be most important to improve antibiotic prescription
and should be further investigated in the Sub-Saharan primary
care setting (24, 48).
Our study raises additional concerns about the quality of
antibiotic prescription. Only a small minority of diagnosis-
antibiotic prescription pairs aligned with guidance from IMCI
or national guidelines. Similarly, a study from Zanzibar reported
that only 22% of antibiotic prescriptions were appropriate for
the diagnosis (37). Broad-spectrum antibiotics were commonly
prescribed and dosing errors were frequent, fueling antimicrobial
resistance. Despite the availability of all essential medicines at
the facilities during the study, providers opted for second-line
agents and non-indicated antibiotics. Our data indicate that
health workers would benefit from increased support in picking
the correct weight-based dosing. Our findings point to possible
avenues that would have to be addressed in a primary care
antibiotic stewardship programs.
Another consequence of prescribing non-essential medicines
is the additional cost-incurred by parents. One-third of patients
were prescribed additional non-evidence-based treatments such
as vitamins and cough syrup, putting additional financial burden
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on families and incurring potential safety risks in children (e.g.,
domperidone and bella donna).
CONCLUSION
The observations from this descriptive study and its limitations
again point to the complexity of quality of care in pediatric
primary care in Africa. Current evidence in Tanzania is largely
limited to small-scale, fragmented reports or focusing on hospital
settings or malaria case-management specifically (52, 53). In
addition to previous evidence, our report points to challenges in
using diagnostic tests other than mRDT, concerns regarding the
quality of antibiotic prescriptions, and the frequent prescription
of non-evidence based complementary medicines. Future efforts
should focus on larger, systematic studies, which include a variety
of methods to assess the quality of primary care diagnostic and
treatment processes (54, 55). Such methods should combine
systematic monitoring with more granular data generation to
explain mechanisms for change. In the meantime, effective
solutions to support primary health care workers in case
management of children are urgently needed.
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